LIGAND PHARMACEUTICALS INC (LGND)

LIGAND PHARMACEUTICALS INC (LGND) scores 64 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 166.3, representing a 17% premium to fair value. Quantitative score: 57/100. Qualitative score: 90/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full LGND analysis on boothcheck